Archives

  • TGI and MAHE to launch a course on leadership in public health at New Delhi

    The George Institute for Global Health, India and the Manipal Academy of Higher Education (MAHE) have joined hands to offer

    Read More
  • Sanofi : Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes

    Children and adolescents (aged 6 to 17 years) living with type 1 diabetes achieved comparable reduction in average blood sugar

    Read More
  • Polyplus-transfection expands GMP portfolio to deliver flexibility for gene and cell therapy manufacturing

    Polyplus-transfection(R) SA, the leading biotechnology company that supports gene and cell therapy by supplying innovative transfection solutions, today announces the

    Read More
  • Bristol-Myers Squibb gets FDA breakthrough therapy status for Orencia to prevent GvHD

    Bristol-Myers Squibb (BMS) has secured breakthrough therapy status from the US Food and Drug Administration (FDA) for its Orencia (abatacept)

    Read More
  • Novartis breadth of data at 2019 ASH demonstrates commitment to reimagining medicine in hematology through innovative therapeutic platforms

    Novartis looks forward to presenting data from the company’s expansive hematology portfolio at the upcoming 61st American Society of Hematology

    Read More

Archive

Offers